Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Eye-Tracking Wheelchair Helps the Severely Disabled Steer New Course

July 7, 2014 3:42 pm | by Reuters | Videos | Comments

Scientists in London have developed an algorithm-based decoder system that enables wheelchair users to move around simply by looking to where they wish to travel. The researchers at Imperial College London say the system is inexpensive and...

TOPICS:

Scientists Criticize Europe's $1.6B Brain Project

July 7, 2014 3:37 pm | by Frank Jordans and John-Thor Dahlburg, The Associated Press | News | Comments

Dozens of neuroscientists are protesting Europe's $1.6 billion attempt to recreate the functioning of the human brain on supercomputers, fearing it will waste vast amounts of money and harm neuroscience in general. The 10-year Human Brain...

TOPICS:

Preventive Placement of ICDs for Less Severe Heart Failure May Improve Survival

July 7, 2014 3:20 pm | by JAMA - Journal of the American Medical Association | News | Comments

An examination of the benefit of preventive placement of implantable cardioverter-defibrillators (ICDs) in patients with a less severe level of heart failure, a group not well represented in clinical trials, finds significantly better survival...

TOPICS:
Advertisement

EarlySense Chair Sensor Receives FDA Clearance

July 7, 2014 3:09 pm | by PR Newswire | News | Comments

EarlySense, the market leader in contact free monitoring solutions, has announced the market clearance by the US Food and Drug Administration for the Chair Sensor Solution. The Chair Sensor, which continuously monitors patient's Heart Rate...

TOPICS:

First Evidence for Painless Atrial Fibrillation Treatment

July 7, 2014 2:35 pm | by European Society of Cardiology | News | Comments

The first evidence for a shockless treatment for atrial fibrillation (AF) was presented Friday at Frontiers in CardioVascular Biology (FCVB) 2014 in Barcelona, Spain. The meeting was organized by the Council on Basic Cardiovascular Science...

TOPICS:

New Optogenetic Tool for Controlling Neuronal Signaling by Blue Light

July 7, 2014 2:29 pm | by Institute for Basic Science | News | Comments

Institute for Basic Science, the main organization of the International Science and Business Belt project in South Korea, has announced that a group of researchers, led by professor Won Do Heo, have developed a new technology in the field of...

TOPICS:

Low-Cost TB Test Means Quicker, More Reliable Diagnosis for Patients

July 7, 2014 2:02 pm | by Texas A&M University Health Science Center | News | Comments

A new test for tuberculosis (TB) could dramatically improve the speed and accuracy of diagnosis for one of the world's deadliest diseases, enabling health care providers to report results to patients within minutes, according to a study published...

TOPICS:

Rapid Surgical Innovation Puts Patients at Risk for Medical Errors

July 7, 2014 1:55 pm | by University of California - San Diego | News | Comments

Researchers at the University of California, San Diego School of Medicine have found that the risk of patient harm increased two-fold in 2006 – the peak year that teaching hospitals nationwide embraced the pursuit of minimally invasive robotic...

TOPICS:
Advertisement

Pseudogenes May Provide Clearer Understanding of Biomarkers

July 7, 2014 1:50 pm | by University of Texas M. D. Anderson Cancer Center | News | Comments

Alas, the thankless pseudogene. Dysfunctional, unloved and seemingly of little use, these poor-cousin relatives of genes have lost their protein-coding abilities. They contain material not essential for an organism's survival and are the...

TOPICS:

Concern at Lack of Teenage Patients in Cancer Trials

July 7, 2014 1:45 pm | by Cancer Research UK | News | Comments

Age limits on clinical trials need to be more flexible to allow more teenage cancer patients the chance to access new treatments, according to a report from the National Cancer Research Institute (NCRI), published in the Lancet Oncology. The...

TOPICS:

Dental Pulp Stem Cells Promote the Survival and Regeneration of Retinal Cells After Injury

July 7, 2014 1:41 pm | by Neural Regeneration Research | News | Comments

Researchers at the University of Birmingham, UK, led by Dr. Ben Scheven, Dr. Wendy Leadbeater and Ben Mead have discovered that stem cells isolated from the teeth, termed dental pulp stem cells (DPSC), can protect retinal ganglion cells (RGCs)...

TOPICS:

DNA Origami Nano-Tool Provides Important Clue to Cancer

July 7, 2014 1:38 pm | by Karolinska Institutet | News | Comments

Researchers at Karolinska Institutet in Sweden have headed a study that provides new knowledge about the EphA2 receptor, which is significant in several forms of cancer. This is important knowledge in itself – but just as important is how...

TOPICS:

Breaking Down the Regulation of LDTs: Public Health, First Amendment, and Innovation

July 7, 2014 11:52 am | by Richard Park, Contributing Editor | Blogs | Comments

According to the letter, for the past 38 years, the FDAs of seven Presidential administrations have failed to confront the problem of the existence of dual regulatory systems for IVDs and LDTs. To compensate for this, the agency has attempted...

TOPICS:

Infographic: Insulin Pumps Beat Injections in Type 2 Diabetes Management

July 7, 2014 11:17 am | by Medtronic | News | Comments

In the OpT2mise trial, those using insulin pumps achieved a mean A1C (average blood glucose) reduction of 1.1 percent compared to only a 0.4 percent reduction by those using multiple daily injections. This improvement in glucose control was...

TOPICS:

Type 2 Diabetes Patients Achieve Superior Outcomes with Insulin Pumps vs. Multiple Daily Injections

July 7, 2014 11:17 am | by Medtronic | News | Comments

As an example of its commitment to improving clinical outcomes for all people with diabetes, Medtronic, Inc. has announced the results of the OpT2mise trial, which showed that MiniMed insulin pumps safely achieve better glucose control for...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading